Analysts’ upgrades for Monday, October 23rd:

athenahealth (NASDAQ:ATHN) was upgraded by analysts at First Analysis from an underweight rating to an equal weight rating. First Analysis currently has $127.00 price target on the stock, up from their previous price target of $125.00.

CAI International (NYSE:CAI) was upgraded by analysts at Cowen and Company from a market perform rating to an outperform rating. They currently have $46.00 target price on the stock, up from their previous target price of $34.00.

Cemex S.A.B. de C.V. (NYSE:CX) was upgraded by analysts at Citigroup Inc. from a sell rating to a neutral rating.

Dr Pepper Snapple Group (NYSE:DPS) was upgraded by analysts at Wells Fargo & Company from a market perform rating to an outperform rating.

General Electric (NYSE:GE) was upgraded by analysts at Bank of America Corporation from a neutral rating to a buy rating.

Illumina (NASDAQ:ILMN) was upgraded by analysts at Deutsche Bank AG from a hold rating to a buy rating.

J.B. Hunt Transport Services (NASDAQ:JBHT) was upgraded by analysts at UBS AG from a neutral rating to a buy rating.

Mulesoft (NASDAQ:MULE) was upgraded by analysts at Canaccord Genuity from a hold rating to a buy rating.

ServiceNow (NYSE:NOW) was upgraded by analysts at Piper Jaffray Companies from a neutral rating to an overweight rating.

Ocean Rig UDW (NASDAQ:ORIG) was upgraded by analysts at DNB Markets from a hold rating to a buy rating.

Science Applications International Corporation (NYSE:SAIC) was upgraded by analysts at Citigroup Inc. from a neutral rating to a buy rating.

SM Energy (NYSE:SM) was upgraded by analysts at J P Morgan Chase & Co from a neutral rating to an overweight rating.

ProNAi Therapeutics (NASDAQ:SRRA) was upgraded by analysts at Jefferies Group LLC from a hold rating to a buy rating.

Tate & Lyle PLC (OTCMKTS:TATYY) was upgraded by analysts at Jefferies Group LLC from a hold rating to a buy rating.

TerraForm Power (NASDAQ:TERP) was upgraded by analysts at Robert W. Baird from a neutral rating to an outperform rating. The firm currently has $19.00 price target on the stock, up from their previous price target of $13.00.

Receive News & Ratings for athenahealth Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc and related companies with MarketBeat.com's FREE daily email newsletter.